NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Binani Industries has responded to NSE's clarification request regarding its Q2 FY25 financial results, citing auditor errors for subsidiary count discrepancies and technical faults for filing delays. The company's financial position is extremely weak, with accumulated losses of ₹21,682 lakhs and a fully eroded net worth. Liabilities exceed total assets by ₹18,543 lakhs, leading auditors to conclude that the 'going concern' assumption is no longer valid. Consequently, the financial statements have been prepared on a liquidation basis, reflecting severe financial distress.
முக்கிய அம்சங்கள்
Accumulated losses reached ₹21,682 lakhs with liabilities exceeding assets by ₹18,543 lakhs as of September 30, 2024.Auditors stated the 'going concern' assumption is inappropriate and financials are prepared on a liquidation basis.Outstanding corporate guarantees and letters of comfort total approximately ₹13,196 lakhs for erstwhile subsidiaries.Reported a standalone net loss of ₹54 lakhs for Q2 FY25 on zero operating income.Clarified that one subsidiary was struck off in FY 2023-24, leading to previous reporting errors by auditors.
👀 கவனிக்க வேண்டியவை
Investors should exercise extreme caution as the company's net worth is fully eroded and it is being valued on a liquidation basis. The significant contingent liabilities and lack of a clear business plan suggest a very high risk of capital loss.
Park Medi World Launches Panchkula Hospital; Group Bed Capacity to Reach 5,460 by 2028
Park Medi World Limited has officially launched its multi-super specialty hospital in Panchkula, strengthening its footprint in the Tricity region alongside its Mohali expansion. The group currently operates 16 hospitals with 3,960 beds and is North India's second-largest hospital chain. The company is executing an aggressive growth plan to add 1,500 beds through five new hospitals and existing facility expansions. This strategic move aims to reach a total capacity of 5,460 beds by March 2028, focusing on high-margin tertiary and quaternary care services.
முக்கிய அம்சங்கள்
Launched a new multi-super specialty hospital in Panchkula, targeting a combined Tricity capacity of 850 beds.Currently operates 16 hospitals with a total capacity of 3,960 beds across North India.Planned addition of 1,500 beds through 5 new hospitals and existing facility expansions.Projected total bed capacity to reach 5,460 beds by March 2028.Focus on high-acuity care including oncology, neurosciences, and robotic-assisted procedures.
👀 கவனிக்க வேண்டியவை
Investors should monitor the occupancy rates and ramp-up speed of the new Panchkula facility as it will be a key revenue driver. The company's aggressive 38% capacity expansion plan by 2028 signals strong long-term growth potential in the healthcare sector.
Paradeep Phosphates has successfully commissioned a new 300 TPD Sulphuric Acid Plant at its Mangalore unit as of March 31, 2026. This expansion increases the company's total sulphuric acid capacity from 100 TPD to 400 TPD, involving a total investment of approximately Rs. 240 Crores. The project, funded through internal accruals and term loans, is designed to reduce dependence on imported raw materials and improve operational margins. Furthermore, the plant will utilize waste heat to generate 1,05,000 tonnes of steam annually, significantly enhancing energy efficiency and reducing carbon emissions.
முக்கிய அம்சங்கள்
Successfully commissioned 300 TPD Sulphuric Acid Plant, increasing total capacity to 400 TPDTotal project investment of approximately Rs. 240 Crores funded via internal accruals and term loansExpected to generate 1,05,000 tonnes of high-pressure steam annually from process waste heatAims to reduce CO2 emissions by 19,000 tonnes per year by replacing fossil fuel-based steamEnhances captive production to reduce import dependence and ensure raw material security
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for long-term margin expansion and vertical integration. Monitor the company's upcoming quarterly results for improvements in operating efficiency and cost savings.
EID Parry to Close PSRIPL Refinery; To Provision Rs 655 Crore for Liabilities
EID Parry has decided to shut down the refinery operations of its wholly-owned subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL), effective March 31, 2026, due to structural unviability and accumulated losses of Rs 1,406 crore. To settle the subsidiary's liabilities, EID Parry will infuse up to Rs 610 crore in equity and provide a loan of Rs 130 crore. The company expects to create a provision of approximately Rs 655 crore across FY 2025-26 and FY 2026-27, alongside a Rs 46 crore investment impairment. While this stops future operational losses, the immediate financial impact on the consolidated balance sheet is substantial.
முக்கிய அம்சங்கள்
Closure of 2,000 TPD sugar refinery at Kakinada due to accumulated losses of Rs 1,406 crore as of March 2025.EID Parry to create a financial provision of ~Rs 655 crore over the next two fiscal years.Board approved equity infusion of Rs 610 crore and an inter-corporate loan of Rs 130 crore to settle subsidiary debts.Subsidiary bank borrowings stand at Rs 877 crore, with only Rs 137 crore expected to be settled via asset realization.Impairment of Rs 46 crore to be recognized on the current carrying value of the investment in PSRIPL.
👀 கவனிக்க வேண்டியவை
Investors should expect significant pressure on profitability in FY26 and FY27 due to the Rs 655 crore provisioning. While the move eliminates a loss-making segment, the short-term financial hit and the scale of the write-off are major concerns.
EID Parry to Close PSRIPL Refinery; to Infuse Rs 740 Cr to Settle Liabilities
EID Parry has announced the closure of its wholly-owned subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL), effective March 31, 2026, due to structural unviability and accumulated losses of Rs 1,406 crore. To settle the subsidiary's bank borrowings of Rs 877 crore, EID Parry will infuse up to Rs 610 crore in equity and Rs 130 crore in loans. This move will result in a significant financial hit, with the company expected to create provisions of approximately Rs 655 crore across FY26 and FY27, plus a Rs 46 crore impairment charge.
முக்கிய அம்சங்கள்
Closure of the 2,000 TPD Kakinada sugar refinery which had accumulated losses of Rs 1,406 crore as of March 2025.Parent company to infuse Rs 740 crore total (Rs 610 Cr equity and Rs 130 Cr loan) to settle outstanding bank debts.Estimated provisioning of Rs 655 crore to be recognized across FY 2025-26 and FY 2026-27.Additional impairment of Rs 46 crore on the current carrying value of the investment in PSRIPL.PSRIPL contributed Rs 4,262.45 crore to consolidated revenue in FY25 but had a negative net worth.
👀 கவனிக்க வேண்டியவை
Investors should expect significant pressure on EID Parry's profitability in the short term due to the Rs 655 crore provisioning. While the closure eliminates a loss-making unit, the immediate financial burden and cash outflow are substantial.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Apeejay Surrendra Park Hotels Appoints Rohit Kakra as COO for Flurys Brand
Apeejay Surrendra Park Hotels Limited has appointed Mr. Rohit Kakra as Chief Operating Officer and Senior Management Personnel, effective April 1, 2026. Mr. Kakra will specifically oversee the operations of the company's iconic bakery and confectionery brand, 'Flurys.' With over 23 years of experience in F&B retail, including a previous stint as COO of Costa Coffee at Devyani International, his appointment is aimed at driving operational efficiencies and performance. This move signals a strategic focus on scaling the Flurys brand within the company's portfolio.
முக்கிய அம்சங்கள்
Appointment of Rohit Kakra as COO and Senior Management Personnel effective April 1, 2026Mr. Kakra brings over 23 years of extensive experience in the F&B retail sectorRole focused on strengthening operational efficiencies and performance for the 'Flurys' brandPrevious leadership experience includes COO at Costa Coffee and VP Operations at Awfis Space SolutionsEducational background includes IHM Bangalore and a Post Graduate Program from Welingkar Institute
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward professionalizing and scaling the high-margin Flurys brand. Monitor the brand's expansion and operational performance in upcoming quarterly reports.
Paras Defence Divests 58.02% Stake in Ayatti Innovative for Rs 6.99 Crore
Paras Defence and Space Technologies has completed the divestment of its entire 58.02% equity stake in its subsidiary, Ayatti Innovative Private Limited. The transaction was executed for a total cash consideration of Rs 6.99 crore with Unifab Ultra Technologies LLP. Ayatti was a minor part of the business, contributing only 0.32% to the consolidated turnover and carrying a negative net worth of Rs 3.37 crore in FY25. This exit allows Paras Defence to offload an underperforming asset and streamline its portfolio.
முக்கிய அம்சங்கள்
Divested entire 58.02% stake comprising 15,20,000 equity shares.Received total cash consideration of Rs 6,99,20,000 from the buyer, Unifab Ultra Technologies LLP.Exited a subsidiary that had a negative net worth contribution of Rs 3.37 crore in FY24-25.The divested entity contributed a negligible 0.32% (Rs 1.18 crore) to the company's total turnover.Ayatti Innovative Private Limited ceases to be a subsidiary of PARAS effective March 30, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive strategic move to exit a loss-making or negative net worth subsidiary. The cash infusion and removal of a dragging asset should marginally improve consolidated balance sheet health.
Paradeep Phosphates Proposes MD Re-appointment and New Joint MD Appointment
Paradeep Phosphates has issued a postal ballot notice to seek shareholder approval for the re-appointment of Mr. N Suresh Krishnan as Managing Director for a three-year term starting February 16, 2026. The proposed remuneration includes a basic salary of ₹16.91 lakhs per month and perquisites capped at ₹18.43 lakhs per month, alongside performance-linked pay. Additionally, the company is seeking approval for the appointment of Mr. K K Rajeev Nambiar as Joint Managing Director effective April 1, 2026. Shareholders can participate in the e-voting process from March 28 to April 26, 2026.
முக்கிய அம்சங்கள்
Re-appointment of Mr. N Suresh Krishnan as MD for a 3-year tenure (Feb 2026 to Feb 2029)Proposed MD basic salary of ₹16.91 lakhs per month within a range of ₹16-25 lakhsMD perquisites capped at ₹18.43 lakhs per month plus 462,021 ESOP options from FY 2021Appointment of Mr. K K Rajeev Nambiar as Joint Managing Director effective April 1, 2026E-voting period for shareholders scheduled from March 28, 2026, to April 26, 2026
👀 கவனிக்க வேண்டியவை
Investors should monitor the leadership transition and ensure the proposed remuneration packages are commensurate with the company's financial performance and industry benchmarks.
BIL Vyapar CoC Approves Resolution Plan Request and Evaluation Matrix
BIL Vyapar Limited, formerly known as Binani Industries, has announced the outcomes of its 6th Committee of Creditors (CoC) meeting under the Corporate Insolvency Resolution Process (CIRP). The CoC has officially approved the Request for Resolution Plan (RFRP) and the Evaluation Matrix, which are critical steps for inviting and assessing potential bidders for the company. Additionally, the committee ratified the CIRP costs and the appointment of tax consultants. This progress indicates that the insolvency process is moving toward the stage of seeking a formal resolution plan to settle outstanding debts.
முக்கிய அம்சங்கள்
CoC approved the Request for Resolution Plan (RFRP) and Evaluation Matrix via e-voting concluded on March 23, 2026.The 6th meeting of the Committee of Creditors was held on March 13, 2026, to advance the insolvency roadmap.Ratification of CIRP costs and the appointment of Pawan Vani & Associates as Tax Consultants was finalized.The company remains under the Corporate Insolvency Resolution Process (CIRP) as per SEBI and IBC regulations.
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as equity shareholders typically face significant dilution or total loss of value during insolvency resolutions. Monitor the upcoming resolution plans to determine if any value will be preserved for minority shareholders.
Par Drugs and Chemicals Reports Regulatory Action or Orders Passed
Par Drugs and Chemicals Limited has informed the stock exchange regarding specific actions taken or orders passed against the company. The disclosure, dated March 26, 2026, follows mandatory reporting requirements for listed entities. While the brief does not specify the exact nature of the order or any financial penalties, such filings typically involve compliance or legal matters. Investors should remain cautious until the full details of the order's impact on operations are clarified.
முக்கிய அம்சங்கள்
Company officially informed the Exchange about actions taken or orders passed.The filing was signed and dated March 26, 2026, by Sanket Bhupendrabhai Trivedi.Disclosure is made in compliance with SEBI Listing Obligations and Disclosure Requirements.Specific financial impact or nature of the regulatory body was not detailed in the brief.
👀 கவனிக்க வேண்டியவை
Investors should wait for a detailed disclosure to understand if the order involves significant financial penalties or operational restrictions. Monitor the stock for potential volatility following this regulatory update.
Park Medi World Completes 100% Acquisition of SVPD Healthcare and 360-Bed KPIMS Hospital
Park Medi World Limited has successfully completed the acquisition of a 100% stake in SVPD Healthcare Private Limited as of March 20, 2026. This follows the previous acquisition of K P S Wellness Private Limited, collectively giving the company full control over the KP Institute of Medical Sciences (KPIMS) in Agra. KPIMS is a significant healthcare facility with a 360-bed capacity. This strategic move consolidates the company's expansion into the Agra market and adds substantial operational capacity to its portfolio.
முக்கிய அம்சங்கள்
Completed 100% acquisition of SVPD Healthcare Private Limited on March 20, 2026SVPD Healthcare has now become a wholly owned subsidiary of Park Medi WorldFinalizes the takeover of the 360-bed KP Institute of Medical Sciences (KPIMS) in AgraFollows the successful 100% acquisition of K P S Wellness Private Limited completed in January 2026
👀 கவனிக்க வேண்டியவை
Investors should view this as a significant growth milestone that increases the company's bed capacity by 360 units. Monitor the upcoming quarterly results for the revenue contribution and margin impact from the newly integrated Agra facility.
Apar Industries to Invest $5M in US Subsidiary and Rs 10.76 Cr in Renewable Energy SPV
Apar Industries has announced a dual investment strategy to bolster its international presence and optimize energy costs. The board approved a capital infusion of up to USD 5 million into its wholly-owned subsidiary, APAR USA LLC, to support its conductors and cables business lines. Simultaneously, the company is investing Rs 10.76 crores for a 26% stake in a wind-solar hybrid power project in Gujarat through an associate SPV, Clean Max Rudra Private Limited. These moves reflect a strategic focus on expanding the US market footprint and transitioning towards sustainable energy for its operations.
முக்கிய அம்சங்கள்
Approved additional capital contribution of up to USD 5 million in APAR USA LLC for business needs.Investment of Rs 10.76 crores to acquire 26% equity in Clean Max Rudra Private Limited for hybrid power.The hybrid project features 9.90 MVA wind capacity and 7.34 MWp solar capacity in Rajkot, Gujarat.APAR USA LLC reported nil turnover for FY25, indicating the investment is for upcoming operational scale-up.This follows a previous investment of Rs 11.38 crores in the same renewable energy SPV.
👀 கவனிக்க வேண்டியவை
Investors should monitor the revenue ramp-up in the US subsidiary following this capital infusion. The renewable energy investment is a positive move for long-term margin protection against rising power costs.
Promoters of Paramount Communications, Sanjay Aggarwal and Sandeep Aggarwal, purchased a total of 1,41,896 shares on March 16, 2026. The acquisition was valued at approximately ₹46.68 lakhs and conducted through open market transactions on the NSE. This move has marginally increased the total promoter group stake from 49.12% to 49.16%. Such insider buying is typically viewed as a positive indicator of management's confidence in the company's intrinsic value.
முக்கிய அம்சங்கள்
Sanjay Aggarwal (WTD) purchased 80,000 shares worth ₹26.34 lakhsSandeep Aggarwal (MD) purchased 61,896 shares worth ₹20.34 lakhsTotal promoter group holding increased by 0.04% to reach 49.16%Transactions were conducted via open market purchases on the NSE on March 16, 2026
👀 கவனிக்க வேண்டியவை
Promoter buying from the open market is a positive sign of internal confidence. Investors should view this as a supportive factor for the stock price, though the quantum of purchase is relatively small compared to the total capital.
BIL Vyapar Limited Schedules 6th Committee of Creditors Meeting for March 13, 2026
BIL Vyapar Limited, which is currently undergoing the Corporate Insolvency Resolution Process (CIRP), has announced its sixth Committee of Creditors (CoC) meeting. The meeting is scheduled for March 13, 2026, to discuss matters related to the company's insolvency resolution. This follows the company's transition from its former identity as Binani Industries Limited. Investors should be aware that the outcome of these meetings will significantly dictate the company's future structure and debt obligations.
முக்கிய அம்சங்கள்
The 6th meeting of the Committee of Creditors (CoC) is set for March 13, 2026.The company is operating under the Corporate Insolvency Resolution Process (CIRP).Disclosure is made in compliance with Regulation 30 and Schedule III of SEBI LODR Regulations.BIL Vyapar Limited was formerly known as Binani Industries Limited (NSE: BILVYAPAR).
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as equity holders typically face significant value erosion during insolvency proceedings. Monitor subsequent filings for details on any proposed resolution plans or liquidation orders.
Uniparts India Appoints Sandeep Taneja as Group CFO; Rohit Maheshwari Resigns
Uniparts India has announced a transition in its financial leadership with the resignation of CFO Rohit Maheshwari, effective March 12, 2026. The Board has appointed Sandeep Taneja as the new Group CFO starting March 16, 2026, ensuring a swift transition. Mr. Taneja brings over 25 years of global experience, having managed P&Ls ranging from $100 million to $3 billion at major firms like Gates India and Ingersoll Rand. His extensive background in both Indian and US markets is expected to support the company's global financial strategy.
முக்கிய அம்சங்கள்
Rohit Maheshwari resigns as CFO and Key Managerial Personnel effective March 12, 2026.Sandeep Taneja appointed as Group CFO effective March 16, 2026, following a Board meeting on March 11.New CFO Sandeep Taneja possesses 25+ years of global experience, including 10 years in the USA.Mr. Taneja has previously managed P&Ls between $100 million and $3 billion at Gates India and Ingersoll Rand.The appointment includes roles as Key Managerial Personnel under Section 203 of the Companies Act, 2013.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine but significant leadership transition; the high caliber of the incoming CFO is a positive indicator for financial governance. Monitor the upcoming quarterly results for any shifts in financial strategy or commentary under the new leadership.
Park Medi World to Launch 350-Bed Panchkula Hospital and Expand Mohali Facility by 150 Beds
Park Medi World Limited is significantly expanding its footprint in the Tricity region by launching a new multi-super specialty hospital in Panchkula and expanding its Mohali facility. The Panchkula hospital, expandable to 350 beds, will commence operations on March 29, 2026. Additionally, the company will add 150 beds to its existing 350-bed Mohali facility with an investment of Rs. 40 crores funded via internal accruals. These moves will establish the company as the largest private healthcare provider in the region with a total of 850 beds.
முக்கிய அம்சங்கள்
New Panchkula hospital with up to 350 beds to start operations on March 29, 2026.Expansion of Mohali facility by 150 beds (total 500) to be completed within 18 months.Investment of approximately Rs. 40 crores for Mohali expansion funded through internal accruals.Consolidated Tricity capacity to reach 850 beds, creating the region's largest private network.Group-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds.
👀 கவனிக்க வேண்டியவை
Investors should monitor the occupancy ramp-up at the new Panchkula facility and the timely execution of the Mohali expansion as these will be key drivers for revenue growth. The use of internal accruals for expansion is a positive sign of financial health and cash flow generation.
Park Medi World to Add 500 Beds via New Panchkula Hospital and Mohali Expansion
Park Medi World is significantly expanding its footprint in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. Additionally, the board has approved a 150-bed expansion at its Mohali facility, which currently operates at 73% capacity, bringing the total regional capacity to 850 beds. The Mohali expansion involves an investment of approximately Rs. 40 crores, which will be entirely funded through internal accruals. This strategic move is expected to make the company the largest private healthcare network in the Tricity area, focusing on high-margin tertiary and quaternary care.
முக்கிய அம்சங்கள்
Launch of Panchkula Hospital (up to 350 beds) scheduled for March 29, 2026Expansion of Mohali Hospital by 150 beds, increasing its total capacity from 350 to 500 bedsInvestment of Rs. 40 crores for Mohali expansion to be funded via internal accruals over 18 monthsConsolidated Tricity capacity to reach 850 beds, establishing regional market leadershipGroup-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds
👀 கவனிக்க வேண்டியவை
Investors should monitor the successful commissioning of the Panchkula facility and the subsequent ramp-up in occupancy rates. The use of internal accruals for expansion is a positive sign of financial health and cash flow generation.
Park Medi World to Launch Panchkula Hospital & Expand Mohali Capacity to 850 Beds
Park Medi World is significantly scaling its presence in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. The board also approved a 150-bed expansion at its Mohali subsidiary, increasing its capacity from 350 to 500 beds with a Rs. 40 crore investment. These developments will bring the company's total regional capacity to 850 beds, establishing it as the largest private healthcare network in the area. The expansion is strategically funded through internal accruals and targets high-margin quaternary care services.
முக்கிய அம்சங்கள்
New Panchkula hospital to commence operations on March 29, 2026, with capacity up to 350 beds.Approved 150-bed expansion at Mohali facility, increasing total beds there to 500 within 18 months.Consolidated Tricity region capacity to reach 850 beds, establishing regional market leadership.Expansion cost of Rs. 40 crores for the Mohali unit to be funded entirely through internal accruals.Strategic focus on high-acuity specialties including Oncology, Neurosciences, and Robotic Surgeries.
👀 கவனிக்க வேண்டியவை
This expansion strengthens the company's competitive moat in North India and is expected to drive long-term revenue growth through higher-margin specialty services. Investors should monitor the occupancy rates of the new Panchkula facility in the coming quarters.
Paras Defence Bags Rs 80.28 Cr Order from DRDO for Air Defence Optical Systems
Paras Defence and Space Technologies has secured a significant domestic order valued at approximately Rs 80.28 crore from the DRDO, Ministry of Defence. The contract involves the development of High Precision Optical Systems specifically for Air Defence Applications. The execution of this order is expected to be completed within a period of 18 months. This win reinforces the company's specialized position in the high-tech defence optics segment and provides clear revenue visibility for the near term.
முக்கிய அம்சங்கள்
Order value of approximately Rs 80.28 crore including taxesAwarded by DRDO, Ministry of Defence for High Precision Optical SystemsProject execution timeline is 18 months from the date of supply orderFocuses on critical technology for Air Defence Applications
👀 கவனிக்க வேண்டியவை
This contract win is a positive indicator of the company's technical capabilities and its ability to secure high-value government projects. Investors should monitor the company's execution progress and potential for similar high-margin orders in the defence electronics space.
Paras Defence Signs MoU with South Korea's Green Optics for Space and Defence Systems
Paras Defence and Space Technologies Limited has entered into a Memorandum of Understanding (MoU) with Green Optics Co. Ltd., South Korea. The partnership aims to establish a framework for joint development, manufacturing, and business development of high-end optics and optical systems. This collaboration specifically targets the Space and Defence sectors, leveraging Green Optics' expertise in precision design. While the financial implications are not yet quantified, this move strengthens Paras's technical capabilities and market reach in niche defense technologies.
முக்கிய அம்சங்கள்
MoU signed with Green Optics Co. Ltd., South Korea, on March 04, 2026.Collaboration focuses on joint development and manufacturing of Optics & Optical Systems.Target sectors include Space, Defence, and other high-precision applications.Agreement includes business development cooperation in respective geographical regions.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive strategic step toward enhancing technical expertise; monitor for future contract wins resulting from this partnership.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
